Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.84)
# 3,243
Out of 4,983 analysts
207
Total ratings
23.58%
Success rate
-3.48%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.08 | +733.33% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.70 | +1,047.28% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $4.85 | +291.75% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.16 | +85.19% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $2.09 | -4.31% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.37 | +2,036.18% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.98 | +537.58% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.46 | +753.66% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.57 | +855.41% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $56 | $0.76 | +7,316.24% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.92 | +992.90% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.45 | +345.34% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $5.46 | +449.45% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $8.56 | +121.96% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.37 | +575.11% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.99 | +505.57% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.17 | +8,447.01% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.65 | +2,682.07% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.34 | +754.70% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $4.78 | +329,397.91% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $17.40 | +2,773.56% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $21.18 | +1,033.41% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.85 | +4,224.32% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $1.02 | +9,703.92% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $6.30 | +126,884.13% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.25 | +460.00% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.41 | +1,144.81% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $3.08 | +1,198.70% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $9.52 | +89.08% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.41 | +13.38% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $5.18 | +27,699.23% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $49.76 | -51.77% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.48 | +230,981.08% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.52 | +1,249,900.00% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.08
Upside: +733.33%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.70
Upside: +1,047.28%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $4.85
Upside: +291.75%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.16
Upside: +85.19%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $2.09
Upside: -4.31%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.37
Upside: +2,036.18%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.98
Upside: +537.58%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.46
Upside: +753.66%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.57
Upside: +855.41%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $56
Current: $0.76
Upside: +7,316.24%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $0.92
Upside: +992.90%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.45
Upside: +345.34%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $5.46
Upside: +449.45%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $8.56
Upside: +121.96%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.37
Upside: +575.11%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.99
Upside: +505.57%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.17
Upside: +8,447.01%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $0.65
Upside: +2,682.07%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.34
Upside: +754.70%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $4.78
Upside: +329,397.91%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $17.40
Upside: +2,773.56%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $21.18
Upside: +1,033.41%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.85
Upside: +4,224.32%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $1.02
Upside: +9,703.92%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $6.30
Upside: +126,884.13%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.25
Upside: +460.00%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.41
Upside: +1,144.81%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $3.08
Upside: +1,198.70%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $9.52
Upside: +89.08%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $4.41
Upside: +13.38%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $5.18
Upside: +27,699.23%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $49.76
Upside: -51.77%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.48
Upside: +230,981.08%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.52
Upside: +1,249,900.00%